DNA Shed From Colon Cancers Into Bloodstream Guide Chemotherapy

A new research study showed that circulating tumor DNA (ctDNA) — genetic material shed from tumors into the bloodstream — can identify those stage II colon cancer patients who can most benefit from chemotherapy following surgery. Learn more about this study and how patients will benefit.

SEE ALL NEWS

Recent Posts

Novel Bone Marrow Transplant Can Cure Sickle Cell Disease Scientists Identify Epigenetic Key That ‘Opens’ Door to Colon Cancer Co-located Cell Types Help Drive Aggressive Brain Tumors US surgeon general sounds alarm about link between alcohol and cancer Researchers Develop Biomarker Algorithm for Barrett’s Esophagus and Esophageal Cancer Scientists Identify New Epigenetic Approach to Target Colorectal Cancer Lymph Node-Like Structures May Trigger the Demise of Cancer Tumors Drug Combination Prompts Immune Response in Some Resistant Pancreatic Cancers How Hypoxia Helps Cancer Spread